Correction: Exploiting the transcriptional specificity of the alphamethylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer (Oncotarget (2018) 9 (36693-36704) DOI: 10.18632/oncotarget.26401)

Mariya Shapovalova, Julia Davydova, Christine Henzler, Mark Daniel, Scott M. Dehm, Christopher A. Warlick, Aaron M. LeBeau

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been corrected: The proper Grant Support information is shown below: GRANT SUPPORT This research was supported by a Department of Defense Prostate Cancer Research Program Early Investigator Research Award - Predoctoral (MS), Prostate Cancer Foundation Young Investigator Award (AML), Randy Shaver Foundation Research Award (AML), Paul Calabresi NCI K12 Award through Mayo Clinic (AML) and an American Cancer Society Institutional Research Grant (AML).

Original languageEnglish (US)
Pages (from-to)4920
Number of pages1
JournalOncotarget
Volume10
Issue number47
DOIs
StatePublished - Aug 1 2019

Bibliographical note

Publisher Copyright:
© 2019 Impact Journals LLC. All rights reserved.

Fingerprint

Dive into the research topics of 'Correction: Exploiting the transcriptional specificity of the alphamethylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer (Oncotarget (2018) 9 (36693-36704) DOI: 10.18632/oncotarget.26401)'. Together they form a unique fingerprint.

Cite this